248 related articles for article (PubMed ID: 21309261)
1. Pathologic and molecular features of uterine carcinosarcomas.
Lopez-Garcia MA; Palacios J
Semin Diagn Pathol; 2010 Nov; 27(4):274-86. PubMed ID: 21309261
[TBL] [Abstract][Full Text] [Related]
2. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
3. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
Le Gallo M; Rudd ML; Urick ME; Hansen NF; ; Merino MJ; Mutch DG; Goodfellow PJ; Mullikin JC; Bell DW
Cancer; 2018 Jan; 124(1):65-73. PubMed ID: 28940304
[TBL] [Abstract][Full Text] [Related]
4. Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study.
Rosati A; Vargiu V; Certelli C; Arcieri M; Vizza E; Legge F; Cosentino F; Ferrandina G; Fanfani F; Scambia G; Corrado G
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6479-6488. PubMed ID: 36773091
[TBL] [Abstract][Full Text] [Related]
5. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas.
McCluggage WG
Int J Gynecol Cancer; 2002; 12(6):687-90. PubMed ID: 12445244
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the relationship between adenosarcoma and carcinosarcoma and a hypothesis of the histogenesis of uterine sarcomas.
Seidman JD; Chauhan S
Int J Gynecol Pathol; 2003 Jan; 22(1):75-82. PubMed ID: 12496702
[TBL] [Abstract][Full Text] [Related]
7. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.
Moukarzel LA; Ferrando L; Da Cruz Paula A; Brown DN; Geyer FC; Pareja F; Piscuoglio S; Papanastasiou AD; Fusco N; Marchiò C; Abu-Rustum NR; Murali R; Brogi E; Wen HY; Norton L; Soslow RA; Vincent-Salomon A; Reis-Filho JS; Weigelt B
Mol Oncol; 2021 Apr; 15(4):1024-1039. PubMed ID: 33021035
[TBL] [Abstract][Full Text] [Related]
8. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
McCluggage WG
J Clin Pathol; 2002 May; 55(5):321-5. PubMed ID: 11986333
[TBL] [Abstract][Full Text] [Related]
9. Integrated Molecular Characterization of Uterine Carcinosarcoma.
Cherniack AD; Shen H; Walter V; Stewart C; Murray BA; Bowlby R; Hu X; Ling S; Soslow RA; Broaddus RR; Zuna RE; Robertson G; Laird PW; Kucherlapati R; Mills GB; ; Weinstein JN; Zhang J; Akbani R; Levine DA
Cancer Cell; 2017 Mar; 31(3):411-423. PubMed ID: 28292439
[TBL] [Abstract][Full Text] [Related]
10. Uterine sarcomas.
Mbatani N; Olawaiye AB; Prat J
Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
[TBL] [Abstract][Full Text] [Related]
11. Uterine carcinosarcoma: A review of the literature.
Cantrell LA; Blank SV; Duska LR
Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
[TBL] [Abstract][Full Text] [Related]
12. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
Murray SK; Clement PB; Young RH
Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
[TBL] [Abstract][Full Text] [Related]
13. DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.
Segura SE; Pedra Nobre S; Hussein YR; Abu-Rustum NR; Weigelt B; Soslow RA; DeLair DF
Am J Surg Pathol; 2020 Nov; 44(11):1573-1579. PubMed ID: 32804882
[TBL] [Abstract][Full Text] [Related]
14. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
15. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
[TBL] [Abstract][Full Text] [Related]
16. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
Horn LC; Dallacker M; Bilek K
Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
[TBL] [Abstract][Full Text] [Related]
17. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
18. Uterine Carcinosarcomas - Diagnosis and Management.
Denschlag D; Ulrich UA
Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.
de Jong RA; Nijman HW; Wijbrandi TF; Reyners AK; Boezen HM; Hollema H
Mod Pathol; 2011 Oct; 24(10):1368-79. PubMed ID: 21572397
[TBL] [Abstract][Full Text] [Related]
20. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
Kernochan LE; Garcia RL
J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]